Correction to: HIV-1 IN/Pol recruits LEDGF/p75 into viral particles

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Published in:	Retrovirology
Main Authors:	Belete Ayele Desimmie, Caroline Weydert, Rik Schrijvers, Sofie Vets, Jonas Demeulemeester, Paul Proost, Igor Paron, Jan De Rijck, Jan Mast, Norbert Bannert, Rik Gijsbers, Frauke Christ, Zeger Debyser
Format:	Article
Language:	English
Published:	BMC 2020-07-01
Online Access:	http://link.springer.com/article/10.1186/s12977-020-00531-3

Similar Items

LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs.
by: Rik Schrijvers, et al.
Published: (2012-01-01)

LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
by: Lenard S. Vranckx, et al.
Published: (2016-06-01)

PB1704: LEDGF/P75 ASSOCIATED WITH CHEMORESISTANCE IN MIXED-LINEAGE LEUKEMIA
by: Muluembet Akele, et al.
Published: (2023-08-01)

Unlike its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell Survival
by: Siska Van Belle, et al.
Published: (2021-01-01)

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection
by: Suha Saleh, et al.
Published: (2017-01-01)

The BET Family of Proteins Targets Moloney Murine Leukemia Virus Integration near Transcription Start Sites
by: Jan De Rijck, et al.
Published: (2013-11-01)

Y-box-binding protein 1 supports the early and late steps of HIV replication.
by: Caroline Weydert, et al.
Published: (2018-01-01)

Comparison of lentiviral vector titration methods
by: Debyser Zeger, et al.
Published: (2006-07-01)

BET-Independent Murine Leukemia Virus Integration Is Retargeted In Vivo and Selects Distinct Genomic Elements for Lymphomagenesis
by: Ivan Nombela, et al.
Published: (2022-08-01)

The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75
by: Da-Wei Zhang, et al.
Published: (2020-01-01)

The Impact of Lens Epithelium-Derived Growth Factor p75 Dimerization on Its Tethering Function
by: Tine Brouns, et al.
Published: (2024-01-01)

Phenotyping of Rare <i>CFTR</i> Mutations Reveals Distinct Trafficking and Functional Defects
by: Marjolein Ensinck, et al.
Published: (2020-03-01)

High-Affinity Nanobody Against the LEDGF PWWP Domain Inhibits Chromatin Binding In Vitro
by: Thibault Vantieghem, et al.
Published: (2026-05-01)

A symmetric region of the HIV-1 integrase dimerization interface is essential for viral replication.
by: Erik Serrao, et al.
Published: (2012-01-01)

The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.
by: Alan Engelman, et al.
Published: (2008-03-01)

Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting.
by: Heather M Marshall, et al.
Published: (2007-12-01)

Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV—Based Vectors and for a Cure for HIV-1 Infection
by: Eline Pellaers, et al.
Published: (2022-12-01)

Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus
by: Julie Janssens, et al.
Published: (2021-03-01)

LEDGF/p75 Deficiency Increases Deletions at the HIV-1 cDNA Ends
by: Murilo T. D. Bueno, et al.
Published: (2017-09-01)

Characterization of LEDGF/p75 genetic variants and association with HIV-1 disease progression.
by: Peter Messiaen, et al.
Published: (2012-01-01)

Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity
by: Graziella Tocco, et al.
Published: (2023-09-01)

Insight in HIV Integration Site Selection Provides a Block-and-Lock Strategy for a Functional Cure of HIV Infection
by: Zeger Debyser, et al.
Published: (2018-12-01)

Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells
by: Evelyn S. Sanchez-Hernandez, et al.
Published: (2023-08-01)

HIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin
by: Garcia-Rivera Jose A, et al.
Published: (2011-04-01)

LEDGF/p75 and Iws1 participate both cooperatively and independently to distinct steps of HIV transcription
by: S. Emiliani, et al.
Published: (2015-12-01)

Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
by: Anamika Basu, et al.
Published: (2012-01-01)

The GR-LEDGF/p75-HSP27 Axis Contributes to Cross-Resistance Between Enzalutamide and Docetaxel in Prostate Cancer
by: Pedro T. Ochoa, et al.
Published: (2025-10-01)

Linking LEDGF/p75 Overexpression With Microsatellite Instability and KRAS Mutations: A Small-Scale Study in Colorectal Cancer
by: Victoria Liedtke, et al.
Published: (2025-01-01)

Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
by: Weiwei Xue, et al.
Published: (2014-01-01)

Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors
by: Parmit Kumar Singh, et al.
Published: (2022-08-01)

Role of Transportin-SR2 in HIV-1 Nuclear Import
by: Maryam Tabasi, et al.
Published: (2021-05-01)

The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells
by: Greisha L. Ortiz-Hernandez, et al.
Published: (2021-10-01)

Studies on HIV integrase-LEDGF/p75 interaction inhibitory activity of isatine derivative using the alpha screen luminescent proximity assay
by: Selvam Periyasamy
Published: (2012-05-01)

The LEDGIN GS-9822 inhibits HIV-2 infection and enhances HIV-2 latency
by: Anne Bruggemans, et al.
Published: (2026-06-01)

Evaluation of a flavonoid library for inhibition of interaction of HIV-1 integrase with human LEDGF/p75 towards a structure–activity relationship
by: Zhi-Hui Yin, et al.
Published: (2022-12-01)

A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75.
by: Stephen Hare, et al.
Published: (2009-01-01)

A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction site.
by: Tatsuya Maehigashi, et al.
Published: (2021-07-01)

The Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights
by: Peter Cherepanov, et al.
Published: (2009-11-01)

Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma
by: Yuwei Zhang, et al.
Published: (2023-01-01)

Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals.
by: Kim Mous, et al.
Published: (2012-01-01)